Frequently asked questions
In 2022, the global Protein Engineering Market is expected to be worth USD 2154.8 million.
The Protein Engineering Market is estimated to increase at a CAGR of 16.90% between 2023 and 2030, reaching USD 7514.8 Million in 2030.
In 2022, rational protein design was the industry’s dominant force, accounting for more than 29.95% of total revenue
Antibodies are the most in demand in the industry
The insulin category is expected to grow at the fastest CAGR from 2023 to 2030.
North America will dominate the global industry in 2022, accounting for more than 40.75% of total sales, while the Asia Pacific region is predicted to grow at the fastest CAGR.
The top players include Agilent Technologies; Bruker Corp.; Thermo Fisher Scientific, Inc.; PerkinElmer, Inc.; Waters Corp.; Bio-Rad Laboratories; Merck KGaA; Danaher Corp
The market’s primary drivers are rising demand for protein-based treatments, advancements in genetic engineering technologies, and a growing emphasis on customized medicine.
High protein engineering and maintenance costs, The market’s principal obstacles are challenges in maintaining the stability and functionality of altered proteins, as well as ethical concerns associated to genetic manipulation.
The primary opportunity in the market is the growing acceptance of robotic-assisted surgeries, the expansion of protein engineering in the food and beverage industry, and potential applications in agriculture and environmental sustainability.